National Institute of Neurological Disorders and Stroke (NINDS)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institute of Neurological Disorders and Stroke (NINDS) sits in the top decile of US sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count).
National Institute of Neurological Disorders and Stroke (NINDS): 567 sponsored US clinical trials, 48 recruiting.
National Institute of Neurological Disorders and Stroke (NINDS) sponsors 567 registered US clinical trials on ClinicalTrials.gov, 48 of them currently recruiting, and 467 completed. 16 of these trials are in Phase 3-4 (later-stage) and 158 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 23 trials.
Top-decile sponsor footprint
National Institute of Neurological Disorders and Stroke (NINDS) ranks in the top decile of sponsors by registered trial count (#61 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
467 of 508 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
567 total, page 8 of 12
Magnetic Resonance Imaging of the Brain in Social and Emotional Reasoning
NCT00060853
Hypnosis in Autonomic Function
NCT00061009
Magnetic Resonance Imaging of the Brain in Emotional Processing
NCT00061204
Evaluation of Primary Chronic Autonomic Failure
NCT00059033
Brain Plasticity of Verbal Memory in the Blind
NCT00059189
Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity
NCT00057460
The Role of Gene Changes in Brain Tumor Formation and Growth
NCT00059020
Postural Control in the Elderly
NCT00059501
Single Photon Emission Computed Tomography to Study Receptors in Parkinson's Disease
NCT00058721
Development of Techniques for Use in MRI With a Magnetic Field of 7 Tesla
NCT00056914
Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders
NCT00056888
Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement
NCT00056420
Nervous System Function in Normal Volunteers During Cycling Training
NCT00055588
Dextromethorphan to Treat Patients With Voice Spasms
NCT00055549
Transcranial Direct Current Stimulation to Treat Symptoms of Parkinson's Disease
NCT00082342
Ischemic Nerve Block to Improve Hand Function in Stroke Patients
NCT00056706
Registry of Fabry Disease - A Multicenter Observational Study
NCT00055016
Brain Use of Sensory Information to Generate Movement
NCT00055289
Survey of Sensory and Motor Tricks in Focal Dystonia
NCT00054652
Effects of Antiepileptic Drugs on Brain Excitability
NCT00054990
Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome
NCT00051961
Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders
NCT00051337
Brain Encoding for Memory
NCT00051870
Minocycline to Treat Amyotrophic Lateral Sclerosis
NCT00047723
Learning a Motor Task Through Observation
NCT00050869
Rituximab to Treat Neuropathy With Anti-MAG Antibodies
NCT00050245
Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation
NCT00050128
Transcranial Magnetic Stimulation and Electrical Stimulation of Nerves to Study Focal Dystonia
NCT00050024
Alpha-Galactosidase A Replacement Therapy for Fabry Disease
NCT00048906
Effects of Direct Current Brain Stimulation on Cognition
NCT00048698
Brain Inhibition of Muscle Movement in Normal Volunteers
NCT00047957
Transcranial Magnetic Stimulation to Treat Epilepsy
NCT00048490
Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting
NCT00046410
ReoPro and Retavase to Treat Acute Stroke
NCT00046293
Transcranial Magnetic Stimulation to Study Imagination of Movement
NCT00046215
Role of Hormones in Susceptibility to Seizures in Women With Epilepsy
NCT00044252
OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease
NCT00041535
How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance
NCT00040196
MRI Language Studies in Young Children
NCT00039845
Genetic Studies to Identify Stroke Subtypes and Outcome
NCT00357513
JP-1730 to Treat Parkinson's Disease
NCT00040209
Nerve Stimulation to Modify a Spinal Reflex
NCT00039819
Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
NCT00342134
Hypothermia to Treat Severe Brain Injury
NCT00040339
Functional Coupling of Cortico-Cortical and Cortico-Muscular Connections During Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control
NCT00036595
Study of GABA-A Receptors in the Generation of Tics in Patients With Tourette's Syndrome
NCT00034398
Magnetic Resonance Imaging in Children and Adults Using Arterial Spin Tagging Techniques
NCT00034073
Study of Tics in Patients With Tourette's Syndrome and Chronic Motor Tic Disorder
NCT00033995
High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
NCT00034242
MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
NCT00034723
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 78 |
| Phase 3 | 11 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the National Institute of Neurological Disorders and Stroke (NINDS) pipeline
48 recruiting of 567 indexed (8% open); 467 completed (82%).
Phase mix: 16 late (III/IV) vs 158 early (I/II) (early-phase heavy).
Top condition: Healthy (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institute of Neurological Disorders and Stroke (NINDS): open-pipeline peers nationwide
Peers matched on 567 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
National Institute of Neurological Disorders and Stroke (NINDS) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 567 trials (± recruiting share)
- Children's Hospital Medical Center, Cincinnati · 571 trials · 19% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
Sponsors near 8% open enrollment (± trial volume)
- National Jewish Health · 8% recruiting · 83 trials
- ACADIA Pharmaceuticals · 9% recruiting · 35 trials
- Texas Tech University Health Sciences Center, El Paso · 9% recruiting · 35 trials
- Boehringer Ingelheim · 8% recruiting · 515 trials
Related
What to do with this National Institute of Neurological Disorders and Stroke (NINDS) page
567 registered trials is a research-attention snapshot, not an endorsement of National Institute of Neurological Disorders and Stroke (NINDS) or any single study.
- 48 of National Institute of Neurological Disorders and Stroke (NINDS)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institute of Neurological Disorders and Stroke (NINDS) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. National Institute of Neurological Disorders and Stroke (NINDS) pipeline card: 567 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.